cathy

 

Catherine Pachuk, Ph.D.
Assistant Adjunct Professor (Adjunct Faculty) 
Ph:
Email:

 


TRAINING

(1988) University of Pennsylvania, Ph.D, Molecular Biology

(2012) Regulatory Affairs Professional Society, Dual Certificate, Medical Devices and                Pharmaceuticals

Appointment at the Baruch S. Blumberg Institute:      

Adjunct Assistant Professor of Translational Research

Other appointments:

Chief Scientific Officer/Business Unit Head at Somahlution – 2011 to present

 RESEARCH

Dr. Pachuk serves as a Chief Scientist Officer for Somahlution and is a member of the company’s Board of Directors. Dr. Pachuk has twenty-five years R&D leadership experience in the pharmaceutical and biotech sectors with expertise in drug, vaccine and medical device development. She received her Ph.D. in Molecular Virology from the University of Pennsylvania. Following a post-doctoral fellowship at SmithKline Beecham, she joined Apollon, Inc. to develop programs in oligonucleotide- based therapeutics, and subsequently DNA-based vaccines for both viral and oncology indications. Following te acquisitions of Apollon, Inc. by Wyeth-Ayerst Research in 1998 she continued to direct several vaccine programs which resulted in several products being advanced into clinical trials. In 2001, she co-founded Nucleonics, a biotech focused on the development of RNAI-based therapeutics. Until April of 2008, she was VP of Preclinical Research. Dr. Pachuk then went to lead development efforts for Pfizer’s Cambride-based oligonucleotide therapeutic Programs in the areas of Oncology and metabolic disease and was a member of the Executive Leadership Team.